Relapsing-Remitting

Explore clinical trials studying Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsing-Remitting trial results

Completed

NCT04966338

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Qaem International Hospital Rasht, Gilan Province, Iran

Golestan Hospital Ahvāz, Khozestan, Iran

Bouali Hospital, MS Clinic Sari, Mazandaran, Iran

Qaem Hospital Mashhad, Razavi Khorasan Province, Iran

View all 15 locations

Completed

NCT01791244

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Please contact the Merck Communications Service for Recruiting locations Darmstadt, Germany

Research site Angered, Sweden

Research site Ängelholm, Sweden

Research Site Danderyd, Sweden

View all 14 locations

Completed

NCT01578330

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)

Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)

Novartis Investigative Site Bursa, Turkey, Turkey (Türkiye)

Novartis Investigative Site Izmir, Turkey, Turkey (Türkiye)

Completed

NCT00893217

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Los Angeles, California, United States

Washington D.C., District of Columbia, United States

Atlanta, Georgia, United States

Chicago, Illinois, United States

View all 14 locations